共 14 条
[1]
Inducible expression of a CC chemokine liver- and activation-regulated chemokine ( LARC )/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Nakayama T,Fujisawa R,Yamada H,et al. International Immunology . 2001
[2]
Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1 ): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. Nakamura K,Williams IR,Kupper TS. Journal of Investigative Dermatology . 1995
[3]
Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. Dieu-Nosjean MC,Massacrier C,Homey B,et al. The Journal of Experimental Medicine . 2000
[4]
Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis. Ross EL,D’Cruz D,Morrow WJ. The Journal of Rheumatology . 2000
[5]
Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasis. Raychaudhuri SK,Raychaudhuri SP,Farber EM. International Journal of Immunopharmacology . 1998
[6]
Keratinocyte-derived chemotactic cytokines: expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo. Wetzler C,Kampfer H,Pfeilschifter J,et al. Biochemical and Biophysical Research Communications . 2000
[7]
Differential expression of GROalpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. Gillitzer R,Ritter U,Spandau U,et al. Journal of Investigative Dermatology . 1996
[8]
Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Raychaudhuri SP,Jiang WY,Farber EM,et al. Acta Dermato Venereologica . 1999
[9]
Serum chemokines in patients with psoriatic arthritis treated with cyclosporin A. Macchioni P,Boiardi L,Meliconi R,et al. The Journal of Rheumatology . 1998
[10]
Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases. Bornscheuer E,Zillikens D,Schroder JM,et al. Dermatology . 1999